Squarex (PRIVATE:SQRE)

Squarex (PRIVATE:SQRE)


Share Price
0
Change
0 (0 %)
Market Cap
$0.00 m
Proactive Investors - Run By Investors For Investors

Squarex

We are a clinical stage pharmaceutical company developing a topical formulation of the immunomodulator squaric acid dibutyl ester for the prevention of recurrent cold sores (herpes labialis) and other infections caused by Herpes Simplex Virus 1 or Herpes Simplex Virus 2.

More than 9 Million people in the US suffer 6 or greater herpes labialis outbreaks every year with no existing...

Market: PRIVATE:SQRE
Sector: Pharma & Biotech
Website: squarex-pharma.com
col 3
col 4
col 5
col 6

Squarex Timeline

Videos

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use